Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Demodex mites can cause a number of problems, including ocular issues. Several physicians discussed symptoms, what to look for, and ways to treat an infestation. Treatments in development were also discussed.
With more than 1 million new cases each year, herpes zoster is increasing in frequency. Two physicians discussed how to manage complications from herpes zoster, the vaccine for it, and treatment options.
Glaucoma Editor Nathan Radcliffe, MD, introduces the topics covered in the section, including early experience with Durysta, how other sustained therapies can benefit the glaucoma patient following cataract surgery, and how glaucoma care can be streamlined to keep everyone safe in the pandemic.
Newer steroid and NSAID options (and some off-label administration of antibiotics) that are delivered either via injection or intracanalicular insert can help avoid complicating a patient’s drop regimen that is already subject to non-compliance, instillation issues, potential for ocular surface agitation, and more.
Durysta, the sustained-release bimatoprost implant, 10 mcg (Allergan), has been available with FDA approval in the U.S. market for a year now. EyeWorld spoke with two physicians who started offering it as an option to their patients to hear about their experience thus far.
EyeWorld spoke with several glaucoma specialists who discussed changes they’ve noticed in glaucoma as well as in their own practices due to the COVID-19 pandemic. They shared how they’ve adapted to continue patient care and described the changes they think are here to stay post-pandemic.
This may not be the year that COVID-19 “goes away” but rather the year that we use what’s been learned to dig in for the next phase of a longer fight than was ever expected. But even in this still hunkering-down year, practices have to continue to pursue their development plans.
Developing a 2021 medical marketing strategy that is designed to meet the needs of patients in the COVID-19 era requires a change of mindset. Place yourself in patients’ shoes, start identifying relatable 2021 experiences, and convert those into profitable marketing opportunities, as well as chances to improve patient care.
EyeWorld reached out to ASCRS members and members of the EyeWorld Editorial Board to ask how the pandemic has changed practices a year after the historic shutdown of elective medical procedures.
The COVID-19 pandemic hit home for our ophthalmology practices in March 2020, closing our offices and surgicenters for all but emergency patients for 10 weeks. This was the reality for many of us. There was an atmosphere of generalized concern bordering on panic in many locations due to a fear of the unknown.